Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join


Dec 05, 2023 1:15 PM - Dec 07, 2023 7:00 PM

(Central Europe Standard Time)

DIA Global Clinical Trial Disclosure and Data Transparency Conference

This virtual live conference is a must-attend for anyone involved in clinical trials!

Session 7: Transitional Trials: less than a year to get it done!

Session Chair(s)

Matthias  Zerm, PhD

Matthias Zerm, PhD

Lead Expert, Clinical Trial Disclosure and R&D Processes


Merete  Joergensen, MBA, MSc

Merete Joergensen, MBA, MSc

Clinical Disclosure and Transparency Expert, Former EFPIA, CREG Clinical Trials

Merete-J Consulting CVR: 34920818, Denmark

In case your company has ongoing trials in scope for transition, now is the time to start considering how and when to get it done. To ensure trials can continue under the regulation the transition must be completed before end of January 2025 I.e. expected latest submission September 2024. Presentations cover practical examples of transitions completed. What obstacles have sponsors/CROs met and what is important to consider when planning and performing the transitions. Use your option to ask questions directly to those who have tried it and maybe join and contribute your own experience.


Caroline  Correas, MA


Caroline Correas, MA


Associate Director, Global Regulatory Policy

Monique  Al, PhD

Dos and Don’ts

Monique Al, PhD

Central Committee on Research Involving Human Subjects (CCMO), Netherlands

Special advisor CCMO

Sameer  Sharma, MPharm

Sponsor Experience

Sameer Sharma, MPharm

Merck KGaA, Germany

Associate Director, Clinical Trial Transparency

Chris  Bamford, PhD

Sponsor Experience

Chris Bamford, PhD

IQVIA Ltd, United Kingdom

Director, Regulatory Affairs

Seán  Kilbride, PhD

Sponsor Experience

Seán Kilbride, PhD

Regeneron Ireland DAC, Ireland

Director, Regulatory Affairs

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.